Monthly Royalty Fee Sample Clauses

Monthly Royalty Fee. In addition to the Initial Franchise Fee set forth in Section 4.1 hereof, Franchisee in the case of a ground up construction site, agrees to pay Franchisor a continuing monthly royalty fee during the term of this Agreement in an amount equal to:
AutoNDA by SimpleDocs
Monthly Royalty Fee. At all times after the commencement of operations by Licensee, Licensee shall pay ITI a monthly royalty for the preceding month equal to seven percent (7%) of Gross Revenues. In addition, Licensee agrees to pay an additional amount equal to any sales, gross receipts, or similar tax imposed on ITI and calculated solely on payments required to be made by Licensee to ITI under this Agreement, unless such tax is an optional alternative to an income tax otherwise payable by ITI. In no event shall Licensee be required to pay any income tax otherwise payable by ITI. ITI may accept any such payment without prejudice to ITI's right to recover any balance remaining or pursue any remedy available to ITI.
Monthly Royalty Fee. AEMETIS shall pay to CLG a non-refundable, monthly royalty rate fee of 10 United States Cents per gallon of product diesel + jet/kerosene produced (10¢ U.S./gal) in the UNIT by AEMETIS in consideration of the operating license granted by CLG under this Agreement to practice the BIOFUELS ISOCONVERSION PROCESS. Such Monthly Royalty Fee shall be paid in accordance with Article 5 of this Agreement; and upon payment of the full amounts of such Monthly Royalty Fee, AEMETIS shall maintain an operating license to practice the BIOFUELS ISOCONVERSION PROCESS in the UNIT for the PAID-UP CAPACITY obtained. Payments to CLG shall be calculated monthly based on actual product rates from the UNIT and paid by AEMETIS as: (Gallons of product diesel + gallons of product jet/kerosene) x (royalty rate 10¢ U.S./gal) = $U.S. paid to CLG for UNIT production of the previous month. The Monthly Royalty Fee shall be adjusted based upon volume as follows:
Monthly Royalty Fee. A Monthly Royalty Fee shall be paid to APH based on an amount equal to five percent (5%) plus GET of the average per unit rental revenue realized by those units in the ICP hotel rental program. As an example, if there are 100 units in the ICP hotel rental program with an average rental revenue of $1,000 per unit for the month, then 5% of $1,000 is $50 and $50 shall be the Monthly Royalty Fee payable to APH for those units who are subject to this License Agreement. The Monthly Royalty Fee shall be calculated on a monthly basis based on the previous month’s average and billed to the Licensee by the fifth (5th) day of each month and must be received by APH by the fifteenth (15th) day of the month. If the Effective Date of this Agreement is a date other than the 1st of the month, Licensee agrees to pay within five (5) days from receipt of a xxxx from APH for the Monthly Royalty Fee for that month, regardless of the number of days left in the month.
Monthly Royalty Fee of the Rider to Franchise License Agreement is hereby deleted in its entirety and the following is substituted in its place and stead: Attachment B - 6 “Monthly Royalty Fee – Developers Advantage: From the Opening Date of the Hotel, you shall pay a Monthly Royalty Fee representing a percentage of the Gross Rooms Revenue of the Hotel (as defined in Subparagraph 7.b. of the Agreement), in the amounts set forth below: Operating Year Monthly Royalty Fee Year 1* Two percent (2%) of Gross Rooms Revenue Years 2 and 3 Three percent (3%) of Gross Rooms Revenue Years 4 or more Four percent (4%) of Gross Rooms Revenue * through the first twelve (12) full calendar months after the Opening of the Hotel.”

Related to Monthly Royalty Fee

  • Royalty Payments (i) Royalties shall accrue when Licensed Products are invoiced, or if not invoiced, when delivered to a third party or Affiliate.

  • Royalty Payment For all leased substances that are sold during a particular month, Lessee shall pay royalties to Lessor on or before the end of the next succeeding month. Royalty payments shall be accompanied by a verified statement, in a form approved by Lessor, stating the amount of leased substances sold, the gross proceeds accruing to Lessee, and any other information reasonably required by Lessor to verify production and disposition of the leased substances or leased substances products. Delinquent royalties may be subject to late fees and penalties in accordance with Lessor’s Rules.

  • License Fee The Licensee to shall make payment of the License Fee to Licensor on the date of this Agreement. All rights granted to Licensee by Producer in the Beat are conditional upon Licensee’s timely payment of the License Fee. The License Fee is a one-time payment for the rights granted to Licensee and this Agreement is not valid until the License Fee has been paid.

  • Monthly Fee 2.1 The monthly fee is € . The monthly fee includes value-added tax at the statutory rate, which is currently 19%. In the event of changes to the statutory value-added tax payable and/or if any additional taxes/levies have to be paid, the fee specified above may be recalculated accordingly.

  • Earned Royalties GEN-PROBE shall pay to PHRI an earned royalty for each sale of a Licensed Kit. GEN-PROBE shall also pay to PHRI an earned royalty for each performance of a Licensed Assay (other than an Assay performed by a customer using a Licensed Kit). The earned royalty for each Licensed Kit and each Licensed Assay shall be determined according to the remainder of this section.

  • Minimum Royalties If royalties paid to Licensor do not reach the minimum royalty amounts stated in Section 3.3 of the Patent & Technology License Agreement for the specified periods, Licensee will pay Licensor on or before the Quarterly Payment Deadline for the last Contract Quarter in the stated period an additional amount equal to the difference between the stated minimum royalty amount and the actual royalties paid to Licensor.

  • Earned Royalty In addition to the annual license maintenance fee, ***** will pay Stanford earned royalties (Y%) on Net Sales as follows:

  • License Fees and Royalties Consistent with the applicable U.S. DOT Common Rules, the Recipient agrees that license fees and royalties for patents, patent applications, and inventions produced with federal assistance provided through the Underlying Agreement are program income, and must be used in compliance with federal applicable requirements.

  • Minimum Royalty At the beginning of each calendar year during the term of this Agreement, beginning January 1, 2016, Company shall pay to Medical School a minimum royalty of {***}. If the actual royalty payments to Medical School in any calendar year are less than the minimum royalty payment required for that year, Company shall have the right to pay Medical School the difference between the actual royalty payment and the minimum royalty payment in full satisfaction of its obligations under this Section, provided such minimum payment is made to Medical School within sixty (60) days after the conclusion of the calendar year. Waiver of any minimum royalty payment by Medical School shall not be construed as a waiver of any subsequent minimum royalty payment. If Company fails to make any minimum royalty payment within the sixty-day period, such failure shall constitute a material breach of its obligations under this Agreement, and Medical School shall have the right to terminate this Agreement in accordance with Section 8.3.

  • Running Royalties Company shall pay to JHU a running royalty as set forth in Exhibit A, for each LICENSED PRODUCT(S) sold, and for each LICENSED SERVICE(S) provided, by Company or AFFILIATED COMPANIES, based on NET SALES and NET SERVICE REVENUES for the term of this Agreement. Such payments shall be made quarterly. All non-US taxes related to LICENSED PRODUCT(S) or LICENSED SERVICE(S) sold under this Agreement shall be paid by Company and shall not be deducted from royalty or other payments due to JHU. In order to insure JHU the full royalty payments contemplated hereunder, Company agrees that in the event any LICENSED PRODUCT(S) shall be sold to an AFFILIATED COMPANY or SUBLICENSEE(S) or to a corporation, firm or association with which Company shall have any agreement, understanding or arrangement with respect to consideration (such as, among other things, an option to purchase stock or actual stock ownership, or an arrangement involving division of profits or special rebates or allowances) the royalties to be paid hereunder for such LICENSED PRODUCT(S) shall be based upon the greater of: 1) the net selling price (per NET SALES) at which the purchaser of LICENSED PRODUCT(S) resells such product to the end user, 2) the NET SERVICE REVENUES received from using the LICENSED PRODUCT(S) in providing a service, or 3) the net selling price (per NET SALES) of LICENSED PRODUCT(S) paid by the purchaser. No multiple royalties shall be due or payable because any LICENSED PRODUCT(S) or LICENSED SERVICE(S) is covered by more than one claim of the PATENT RIGHTS or by claims of both the PATENT RIGHTS under this Agreement and “PATENT RIGHTS” under any other license agreement between Company and JHU. The royalty shall not be cumulative based on the number of patents or claims covering a product or service, but rather shall be capped at the rate set forth in Exhibit A.

Time is Money Join Law Insider Premium to draft better contracts faster.